Sen. Rand Paul (R-Ky.)
U.S. Government: Agencies/Departments/Divisions | U.S. Senator
Recent News About Sen. Rand Paul (R-Ky.)
-
Rand Paul requests information from TSA on alleged improper surveillance
U.S. Senator Rand Paul (R-KY), Ranking Member of the Senate Homeland Security and Governmental Affairs Committee, has sent a letter to Transportation Security Administration (TSA) Administrator David P. Pekoske requesting information related to the management of watchlists and screening procedures by TSA. This request follows disclosures from whistleblowers raising concerns that mechanisms in the TSA Quiet Skies program may have been used improperly to target individuals based on their political views and participation in constitutionally protected activities.
-
Senator Rand Paul urges CMS reconsideration on noncompliance finding at Fleming County Hospital
U.S. Senator Rand Paul (R-KY) and Congressman Andy Barr (R-KY-06) have jointly sent a letter to the Centers for Medicare & Medicaid Services (CMS), expressing strong concerns over a preliminary noncompliance finding issued to Fleming County Hospital during its recent re-certification as a critical access hospital (CAH).
-
Senators urge FDA to rely on science for MDMA-assisted therapy approval
U.S. Senators Rand Paul (R-KY), Michael Bennet (D-CO), Thom Tillis (R-NC), Kyrsten Sinema (I-AZ), along with 15 other Senate colleagues, have urged U.S. Food and Drug Administration (FDA) Commissioner Robert Califf to prioritize scientific evidence in the consideration of MDMA-Assisted Therapy (MDMA-AT) for treating Post-Traumatic Stress Disorder (PTSD). This therapy could potentially address mental health crises, particularly among American veterans.
-
Senators urge FDA to base decision on MDMA therapy for PTSD on scientific evidence
U.S. Senators Rand Paul (R-KY), Michael Bennet (D-CO), Thom Tillis (R-NC), Kyrsten Sinema (I-AZ), and 15 of their Senate colleagues have urged U.S. Food and Drug Administration (FDA) Commissioner Robert Califf to rely on scientific evidence and data as the FDA considers approving MDMA-Assisted Therapy (MDMA-AT) for treating Post-Traumatic Stress Disorder (PTSD). They argue that MDMA-AT could address the mental health crisis, particularly among American veterans.
-
Senators introduce bipartisan bill to abolish selective service
U.S. Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Cynthia Lummis (R-WY) introduced a bipartisan bill aimed at ending the Selective Service.
-
Bipartisan bill introduced to abolish selective service
U.S. Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Cynthia Lummis (R-WY) have introduced a bipartisan bill aimed at abolishing the Selective Service.
-
Bipartisan bill introduced to abolish selective service
U.S. Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Cynthia Lummis (R-WY) introduced a bipartisan bill aimed at abolishing the Selective Service.
-
Bipartisan bill introduced to abolish selective service
U.S. Senators Rand Paul (R-KY), Ron Wyden (D-OR), and Cynthia Lummis (R-WY) introduced a bipartisan bill to end the Selective Service on August 2, 2024.
-
Lawmakers introduce bill aiming to protect First Amendment rights
FOR IMMEDIATE RELEASE:
-
Senator Rand Paul introduces bill targeting government-directed online censorship
On July 31, 2024, U.S. Senator Rand Paul (R-KY), along with Congresswoman Harriet Hageman (R-WY) and Congressman Dan Bishop (R-NC-08), introduced the Standing to Challenge Government Censorship Act. This legislation aims to prohibit federal employees and contractors from using their positions to direct online platforms to censor speech protected by the First Amendment.
-
Rand Paul introduces bill targeting government-directed online censorship
U.S. Senator Rand Paul (R-KY), joined by Congresswoman Harriet Hageman (R-WY) and Congressman Dan Bishop (R-NC-08), introduced the Standing to Challenge Government Censorship Act on July 30, 2024. The proposed legislation aims to prohibit federal employees and contractors from using their positions to direct online platforms to censor speech protected under the First Amendment.
-
Rand Paul introduces new legislation aimed at protecting First Amendment rights
On July 31, 2024, U.S. Senator Rand Paul (R-KY), alongside Congresswoman Harriet Hageman (R-WY) and Congressman Dan Bishop (R-NC-08), introduced the Standing to Challenge Government Censorship Act in Washington, D.C. This legislation aims to prohibit federal employees and contractors from using their positions to direct online platforms to censor speech protected under the First Amendment.
-
Senator Rand Paul introduces new bill targeting government censorship
Dr. Rand Paul, Rep. Hageman and Rep. Bishop fight to protect Americans’ First Amendment rights again
-
Paul joins Schmitt in effort to reclaim legislative authority from administrative agencies
U.S. Senator Rand Paul (R-KY) has joined forces with U.S. Senator Eric Schmitt (R-MO) in a significant initiative aimed at reclaiming legislative authority from administrative agencies. This move follows the Supreme Court's ruling in Loper Bright, which dismantled the Chevron deference standard.
-
Senators Paul And Schmitt launch initiative targeting legislative authority reclaimation from federal agencies
Dr. Paul joins Sen. Schmitt in efforts to retake legislative authority from unaccountable administrative state
-
Senators push legislative authority shift after Supreme Court ruling
Dr. Paul Joins Sen. Schmitt in Efforts to Retake Legislative Authority from Unaccountable Administrative State
-
Senators launch efforts post-Loper Bright ruling
FOR IMMEDIATE RELEASE:
-
Senators launch effort post-Loper Bright ruling
FOR IMMEDIATE RELEASE:
-
Senators launch efforts against unaccountable administrative state post-Loper Bright ruling
FOR IMMEDIATE RELEASE:
-
Rand Paul introduces act for gain-of-function research oversight
U.S. Senator Rand Paul (R-KY), Ranking Member of the Senate Homeland Security and Governmental Affairs Committee, introduced the Risky Research Review Act on July 10, 2024. This proposal aims to establish a Life Sciences Research Security Board within the Executive Branch to oversee funding for gain-of-function research and other high-risk life sciences research that may pose threats to public health, safety, or national security.